The accelerated healing in burns of treated mice includes the activity of the pentadecapeptide BPC 157 (Figure 1), given locally (as a cream) or systemically (ip), on the inflammatory cells, edema, reticulin, collagen, necrosis, blood vessel formation, number of preserved follicles, re-epithelization, tensile breaking strength, and water content in burned skin
Jump to: How common are headaches on Wegovy | Why Wegovy can cause headaches | Preventing and managing headaches | Eating well to reduce headache risk | Staying active | When to speak to your GP | Frequently asked questions | Take home message Headaches are a common side effect of Wegovy (semaglutide), affecting around 14% of people in clinical trials compared to 10% on placebo
Let's make sure it's a strong one
Tirzepatide (Zepbound/Mounjaro) is available now with insurance coverage options, while retatrutide is only accessible through clinical trials until expected FDA approval in late 20262027